Upcoming events on Novartis

2026-10-27

Earnings release - Q3 2026

Past events on Novartis

2026-07-21

Earnings release - Q2 2026

2026-07-21

Earnings presentation

08:00
2026-04-28

Earnings presentation

08:00
2026-04-28

Earnings release - Q1 2026

2026-03-06

Annual General Meeting

04:00
2026-03-06

Présentation aux Actionnaires / Analystes

04:00
2026-02-04

Earnings presentation

08:00
2026-02-03

Earnings release - Q4 2025

2025-12-01

Information meeting

10:00
2025-11-20

Présentation aux Actionnaires / Analystes

03:00
2025-11-20

Présentation aux Actionnaires / Analystes

04:15
2025-10-30

Information meeting

11:30
2025-10-28

Earnings presentation

09:00
2025-10-27

Earnings release - Q3 2025

Past dividends on Novartis

2026-03-10

Ex-dividend date - 3.7 CHF

00:00

Annual results

Fiscal PeriodDecember 2023 2024 2025 2026 2027 2028
Net sales
Million USD
Released
Forecast
Spread
46 660
46 810
-0.32%
51 722
50 407
2.61%
56 674
55 618
1.9%

57 705


61 254


65 073

EBITDA
Million USD
Released
Forecast
Spread
17 937
18 223
-1.57%
21 006
19 819
5.99%
23 415
23 671
-1.08%

23 232


25 178


27 183

EBIT
Million USD
Released
Forecast
Spread
16 372
16 735
-2.17%
19 494
18 983
2.69%
21 889
21 846
0.19%

21 778


23 631


25 619

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
9 123
10 323
-11.63%
13 640
13 560
0.59%
16 352
17 360
-5.81%

16 479


18 399


20 340

Net income
Million USD
Released
Forecast
Spread
14 854
10 329
43.8%
11 939
11 438
4.38%
13 967
14 570
-4.14%

13 951


15 502


17 368

EPS
USD
Released
Forecast
Spread
7,15
5,38
32.95%
5,92
5,53
7%
7,21
7,16
0.7%

7,04


8,25


9,49

Announcement Date31/01/2431/01/2504/02/26-

Quarterly results

Fiscal PeriodJune 2024 Q4 2025 Q1 2025 Q2 2025 Q3 2025 Q4 2026 Q1 2026 Q2 2026 S1 2026 Q3 2026 Q4 2027 Q1 2027 Q2 2027 Q3 2027 Q4
Net sales
Million USD
Released
Forecast
Spread
13 558
12 823
5.73%
13 620
13 116
3.85%
14 836
14 136
4.95%
14 358
13 866
3.55%
13 860
14 077
-1.54%
13 524
13 480
0.33%
14 951
14 057
6.36%
28 475
26 951
5.66%

14 653


14 892













EBITDA
Million USD
Released
Forecast
Spread
5 294











5 338
4 861
9.81%










5 412


5 410













EBIT
Million USD
Released
Forecast
Spread
4 859
4 435
9.56%
5 575
5 272
5.75%
5 925
5 827
1.68%
5 460
5 520
-1.08%
4 929
5 010
-1.62%
4 897
5 215
-6.1%
5 940
5 332
11.4%
10 837
10 246
5.77%

5 530


5 483


5 545


6 370


5 855


5 565

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
3 285
3 478
-5.55%






4 196
4 238
-0.99%






























Net income
Million USD
Released
Forecast
Spread
2 820
2 585
9.08%
3 606
3 255
10.78%
4 024
3 909
2.93%
3 930
3 652
7.61%
2 404
2 414
-0.4%
3 156
3 227
-2.21%
3 257
3 314
-1.72%




3 312


3 369













EPS
USD
Released
Forecast
Spread
1,42
1,30
9.63%
1,83
1,65
10.96%
2,07
1,99
3.77%
2,04
1,87
9.02%
1,26
1,26
0.23%
1,65
1,68
-2.07%
1,71
1,73
-1.43%




1,74


1,78













Announcement Date31/01/2529/04/2517/07/2528/10/2504/02/2628/04/2621/07/2621/07/26------
2026-08-19

Board of Directors Meeting

2026-08-19

Information meeting

23:30
2026-08-19

Earnings release - Q2 2026

2026-08-20

Earnings release - Q2 2026

2026-08-20

Extraordinary General Meeting

02:00
2026-08-20

Earnings presentation

07:30
2026-08-20

Earnings release - Q2 2026

2026-08-20

Board of Directors Meeting

2026-08-20

Earnings release - Q2 2026

2026-08-20

Board of Directors Meeting

Past sector events for Novartis

Today

Earnings release - Q2 2026

Today

Board of Directors Meeting

Today

Earnings release - Q2 2026

Today

Board of Directors Meeting

2026-08-18

Earnings release - Q2 2026

Today

Information meeting

23:30
2026-08-18

Earnings release - Q2 2026

Today

Earnings presentation

22:00
2026-08-18

Extraordinary General Meeting

02:00
2026-08-17

Earnings release - Q2 2026